Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tarsus Pharmaceuticals (TARS) Inventory (2023 - 2025)

Tarsus Pharmaceuticals (TARS) has 2 years of Inventory data on record, last reported at $2.6 million in Q4 2024.

  • For Q4 2024, Inventory fell 15.67% year-over-year to $2.6 million; the TTM value through Dec 2024 reached $2.6 million, down 15.67%, while the annual FY2024 figure was $2.6 million, 15.67% down from the prior year.
  • Inventory reached $2.6 million in Q4 2024 per TARS's latest filing, down from $2.8 million in the prior quarter.
  • Across five years, Inventory topped out at $3.1 million in Q4 2023 and bottomed at $15000.0 in Q3 2023.